Presentation TCT 2013 Risk/Benefit Favors: Medical Therapy First Presenter: David Maron October 28, 2013
Presentation TCT 2013 Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?) Presenter: Maurice Sarano October 28, 2013
Presentation TCT 2013 PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents Presenter: Laura Mauri October 28, 2013
Presentation TCT 2013 Patent Hemostasis: Taking It to the Next Level Presenter: Samir Pancholy October 28, 2013
Presentation TCT 2013 How and When to Use IVUS, OCT, and NIRS for Procedural Guidance Presenter: Gary Mintz October 28, 2013
Presentation TCT 2013 State-of-the-Art: How Do We Prevent Hospital Admissions? Presenter: Ileana Pina October 28, 2013
Presentation TCT 2013 2 Case Vignettes in Non-left Main Provisional Stenting: Only 1 Stent Needed Presenter: Thierry Lefevre October 28, 2013
Presentation TCT 2013 And Should Also Be Based on Hemodynamic Assessments: The Dimensionless AR Index Presenter: Jan Kovac October 28, 2013
Presentation TCT 2013 Editorial Comment: Anatomical and Clinical Considerations for Transcatheter Mitral Valve Repair Presenter: Francesco Maisano October 28, 2013